SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

81,879.40 772.75
( 0.95%)

Global Indices

Nasdaq

52,245.46 -165.29
(-0.32%)

Dow Jones

7,531.52 -39.42
(-0.52%)

Hang Seng

61,257.85 798.27
(1.32%)

Nikkei 225

10,782.38 -0.49
(0.00%)

Forex

USD-INR

93.78 -0.25
(-0.27%)

EUR-INR

104.91 0.16
(0.15%)

GBP-INR

125.72 0.20
(0.16%)

JPY-INR

0.59 0.00
(0.02%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Cipla Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500087

INE059A01026

432.1356994

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CIPLA

39.77

113589.06

EPS(TTM)

Face Value()

Div & Yield %

35.35

0.92

Back

Aditya Ispat reports standalone net loss of Rs 0.83 crore in the June 2026 quarter

Aug 15,2026

Net Loss of Aditya Ispat reported to Rs 0.83 crore in the quarter ended June 2026 as against net loss of Rs 0.94 crore during the previous quarter ended June 2025. Sales rose 13.94% to Rs 7.44 crore in the quarter ended June 2026 as against Rs 6.53 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	7.44	6.53	14
OPM %	-5.51	-2.30	-
PBDT	-0.77	-0.61	-26
PBT	-1.11	-0.98	-13
NP	-0.83	-0.94	12

81,879.40 772.75 ( 0.95%)

52,245.46 -165.29 (-0.32%)

7,531.52 -39.42 (-0.52%)

61,257.85 798.27 (1.32%)

10,782.38 -0.49 (0.00%)

93.78 -0.25 (-0.27%)

104.91 0.16 (0.15%)

125.72 0.20 (0.16%)

0.59 0.00 (0.02%)